| Abstrakt: |
This article discusses the importance of involving patients in the process of developing new drugs and how patient authors can bridge the gap between patients and healthcare providers. The article focuses on the collaboration between Eli Lilly Japan and a patient advocacy group in Japan, with the intention of including patient views in medical publications. However, the patients declined to be authors for the publications, highlighting the challenges in involving patient authors. The article emphasizes the need for clear expectations, effective communication, and mutual understanding when collaborating with patients as authors. Overall, involving patients in medical publications can make them more relevant to the real world and support shared treatment decision-making between patients and physicians. [Extracted from the article] |
